S. Luchetti

Medicine & Life Sciences

1. Multiple Sclerosis 100%
2. Parkinson Disease 63%
3. Brain 57%
4. Pregnanolone 54%
5. Purinergic P2X7 Receptors 53%
6. Neurosteroids 50%
7. Pathology 50%
8. Histamine Receptors 50%
9. Biosynthetic Pathways 45%
10. Prefrontal Cortex 42%
11. Brain Diseases 40%
12. Autopsy 39%
13. Steroids 38%
14. 20-alpha-Dihydroprogesterone 38%
15. Neuroprotective Agents 38%
16. Mood Disorders 36%
17. Dehydroepiandrosterone Sulfate 33%
18. Single Nucleotide Polymorphism 31%
19. 1-((5-chloro-1H-indol-2-yl)carbonyl)-4-methylpiperazine 30%
20. Microglia 28%
21. Major Depressive Disorder 26%
22. Substantia Nigra 26%
23. Gyrus Cinguli 25%
24. Cohort Studies 25%
25. Dehydroepiandrosterone 22%
26. Inflammation 22%
27. Messenger RNA 21%
28. Brain-Derived Neurotrophic Factor 19%
29. Protein-Tyrosine Kinases 17%
30. Monocytes 12%
31. Bipolar Disorder 12%
32. alcohol sulfotransferase 11%
33. Macrophages 11%
34. Basal Ganglia 10%
35. Histamine 10%
36. Ketosteroids 10%
37. Chronic Progressive Multiple Sclerosis 10%
38. Up-Regulation 10%
39. Tissue Donors 9%
40. In Vitro Techniques 9%
41. Gene Expression 9%
42. Relapsing-Remitting Multiple Sclerosis 9%
43. Serotonin 9%
44. steroidogenic acute regulatory protein 9%
45. 11-beta-Hydroxysteroid Dehydrogenases 9%
46. Primary Cell Culture 9%
47. Demyelinating Diseases 8%
48. Synucleins 8%
49. Therapeutics 7%
50. Aminobutyrates 7%